IPSC
Century TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IPSC vs peer average
32/100
IPSC vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
MNPR is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $399.33M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IPSC
Century Therapeutics
MNPR
Monopar Therapeutics
Grade
F
C
Momentum
35
65
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs MNPR
IPSC / MNPR
Grade Position
Below peers
IPSC vs. peer average (F vs. D)
32/100
Momentum
35
MNPRValue
41
IPSCSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IPSC
MNPR is the first peer returned for this comparison set.